Scotland’s care regulator, the Care Inspectorate, has issued its Quality Improvement Plan for 2023/24, which features PainChek as a key technology.
The Care Inspectorate’s strategy is built around four key pillars aimed at improving quality and participation: quality improvement capacity and capability, innovation, involvement and equalities, and quality improvement support.
A critical component of the ‘innovation’ pillar is phase two of the Care Inspectorate’s ‘test of change’ initiative. This initiative focuses on trialling PainChek – the world’s first regulatory-cleared medical device for the assessment of pain – with up to 15 services, with the aim of improving pain assessment and enhancing the overall quality of care.
The endorsement from the Care Inspectorate supports the expansion of PainChek in the UK, providing a pathway to more than 440,000 aged care beds and across broader social care services.
Tandeep Gill, head of business development UK & Ireland, said: “We are delighted that the Care Inspectorate in Scotland has placed PainChek at the forefront of innovation in its quality improvement plan. Over the last 12 months, PainChek has been working collaboratively with the Care Inspectorate on an improvement pilot in Lothian, with positive outcomes including medication optimisation, reductions in falls, and reduced dependency rates, as pain is being promptly identified and monitored using the PainChek system.”